EP3458053
USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
19.5.2017EP published:
8.12.2021EP application number:
17800310.9
EPO information:
European Patent Register
Max expiry date:
18.5.2037
Title in English:
USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERSLanguage of the patent:
English
Timeline
Today
19.5.2017EP application
8.12.2021EP Publication
Owner
Name:
Biohaven Pharmaceutical Holding Company Ltd.Address:
234 Church Street Suite 301, New Haven, CT 06520, US
Inventor
Name:
CORIC, VladimirAddress:
New Haven Connecticut 06520, US
Priority
Number:
201662339433 PDate:
20.5.2016Country:
US
Classification
Categories:
A61K 31/428, C07D 277/82, A61P 35/00